Acute doxorubicin cardiotoxicity involves cardiomyocyte apoptosis

Cancer Research

Volumn 60, Issue 7, 2000, Pages 1789-1792

  Arola, Olli J ^a   Saraste, Antti ^a   Pulkki, Kari ^a   Kallajoki, Markku ^a   Parvinen, Martti ^a   Voipio Pulkki, Liisa Maria ^a,b  

^a UNIVERSITY OF TURKU   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; DOXORUBICIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CARDIOTOXICITY; CONTROLLED STUDY; CYTOSKELETON; DNA STRAND BREAKAGE; DOSE TIME EFFECT RELATION; DRUG MECHANISM; HEART CONTRACTION; HEART MUSCLE CELL; HISTOPATHOLOGY; MALE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; APOPTOSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; HEART; IN SITU NICK-END LABELING; MALE; MYOCARDIUM; RATS; RATS, WISTAR; TIME FACTORS;

EID: 0034085810     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Gianni, L., and Myers, C. E. The role of free radical formation in the cardiotoxicity of anthracycline. In: F. M. Muggia, M. D. Green, and J. L. Speyer (eds.), Cancer Treatment and the Heart, pp. 9-46. Baltimore: The John Hopkins University Press, 1992.
2. Dorr, R. T. Cytoprotective agents for anthracyclines. Semin. Oncol., 23 (Suppl. 8): 23-34, 1996.
3. Zhang, J., Clark, J. R., Herman, E. H., and Ferrans, V. J. Dendritic cells in the hearts of spontaneously hypertensive rats treated with doxorubicin with or without ICRF-187. Am. J. Pathol., 142: 1916-1926, 1993.
4. Molinari, A., Calcabrini, A., Crateri, P., and Arancia, G. Interaction of anthracyclinic antibiotics with cytoskeletal components of cultured carcinoma cells (CG5). Exp. Mol. Pathol., 53: 11-33, 1990.
5. Jaenke, R. S. An anthracycline antibiotic-induced cardiomyopathy in rabbits. Lab. Investig., 30: 292-304, 1974.
6. Lewis, W., and Gonzales, B. Anthracycline effects on actin and actin-containing thin filaments in cultured neonatal rat myocardial cells. Lab. Investig., 54: 416-423, 1986.
7. Billingham, M. E., Mason, J. W., Bristow, M. R., and Daniels, J. R. Anthracycline cardiomyopathy monitored by morphologic changes. Cancer Treat. Rep., 62: 865-872, 1978.
8. Lefrak, E. A., Pitha, J., Rosenheim, S., and Gottlieb, J. A. A clinicopathologic analysis of Adriamycin cardiotoxicity. Cancer (Phila.), 32: 302-314, 1973.
9. Saraste, A., Pulkki, K., Henriksen, K., Kallajoki, M., Parvinen, M., and Voipio-Pulkki, L-M. Apoptosis in human acute myocardial infarction. Circulation. 95: 320-323, 1997.
10. Olivetti, G., Abbi, R., Quaini, F., Kajstura, J., Cheng, W., Nitahara, J. A., Quaini, E., di Loreto, C., Beltrami, C. A., Krajewski, S., Reed, J. C., and Anversa, P. Apoptosis in the failing human heart. N. Engl. J. Med., 336: 1131-1141, 1997.
11. Saraste, A., Pulkki, K., Kallajoki, M., Heikkilä, P., Laine, P., Mattila, S., Nieminen, M. S., Parvinen, M., and Voipio-Pulkki, L-M. Cardiomyocyte apoptosis and progression of heart failure to transplantation. Eur. J. Clin. Investig., 29: 380-386, 1999.
12. Ling, Y. H., Priebe, W., and Perez-Soler, R. Apoptosis induced by anthracycline antibiotics in P388 parent and multidrug-resistant cells. Cancer Res., 53: 1845-1852, 1993.
13. Zhang, J., Clark, J. R., Herman, E. H., and Ferrans, V. J. Doxorubicin-induced apoptosis in spontaneously hypertensive rats: differential effects in heart, kidney and intestine, and inhibition by ICRF-187. J. Mol. Cell. Cardiol., 28: 1931-1943, 1996.
14. Unverferth, B. J., Magorien, R. D., Balcerzak, S. P., Leier, C. V., and Unverferth, D. V. Early changes in human myocardial nuclei after doxorubicin. Cancer (Phila.), 52: 215-221, 1983.
15. Iliskovic, N., and Singal, P. K. Lipid lowering: an important factor in preventing Adriamycin-induced heart failure. Am. J. Pathol., 150: 727-734, 1997.
16. Saraste, A. Morphologic criteria and detection of apoptosis. Herz, 24: 189-195, 1999.
17. Lockard, V. G., and Bloom, S. Trans-cellular desmin-lamin B intermediate filament network in cardiac myocytes. J. Mol. Cell. Cardiol., 25: 303-309, 1993.
18. Delpy, E., Hatem, S. N., Andrieu, N., Rücker-Martin, C., Jaffrézou, J-P., Levade, T., Laurent, G., and Mercadier, J-J. The anthracycline doxorubicin induces ceramide accumulation and apoptosis in rat ventricular myocytes. Eur. Heart J., 19: 259, 1998.
19. Ito, H., Shimojo, T., Fujisaki, H., Tamamori, M., Ishiyama, S., Adachi, S., Abe, S., Marumo, F., and Hiroe, M. Thermal preconditioning protects rat cardiac muscle cells from doxorubicin-induced apoptosis. Life Sci., 64: 755-761, 1999.
20. Chen, J., and Chien, K. R. Complexity in simplicity: monogenic disorders and complex cardiomyopathies. J. Clin. Investig., 103: 1483-1485, 1999.
21. Yaoita, H., Ogawa, K., Machara, K., and Maruyama, Y. Attenuation of ischaemia/reperfusion injury in rats by a caspase inhibitor. Circulation, 97: 276-281, 1998